Endothiopeptide inhibitors of HIV-1 protease. 1998

S Yao, and R Zutshi, and J Chmielewski
Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.

Endothiopeptide inhibitors of HIV-1 protease were synthesized by chemical and enzymatic methods to individually replace each backbone amide bond in 1 with a thioamide-linkage. Interestingly, agent 7, which contains a thioamide-linkage between the P2' and P3' positions of 1, was the most potent, competitive inhibitor of HIV-1 protease with a Ki of 3.4 microM.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D013854 Thioamides Organic compounds containing the radical -CSNH2. Thioamide
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D018716 Molecular Mimicry The structure of one molecule that imitates or simulates the structure of a different molecule. Antigenic Mimicry,DNA Mimicry,Mimicry, Molecular,Antigen Mimicry,Antigen Mimicries,Antigenic Mimicries,DNA Mimicries,Mimicries, Antigen,Mimicries, Antigenic,Mimicries, DNA,Mimicries, Molecular,Mimicry, Antigen,Mimicry, Antigenic,Mimicry, DNA,Molecular Mimicries

Related Publications

S Yao, and R Zutshi, and J Chmielewski
June 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S Yao, and R Zutshi, and J Chmielewski
April 2001, Drug discovery today,
S Yao, and R Zutshi, and J Chmielewski
January 1997, AIDS clinical review,
S Yao, and R Zutshi, and J Chmielewski
January 1992, Journal of enzyme inhibition,
S Yao, and R Zutshi, and J Chmielewski
July 1999, Organic letters,
S Yao, and R Zutshi, and J Chmielewski
September 2002, Biological chemistry,
S Yao, and R Zutshi, and J Chmielewski
March 2002, Expert opinion on investigational drugs,
S Yao, and R Zutshi, and J Chmielewski
January 1998, Pharmazie in unserer Zeit,
S Yao, and R Zutshi, and J Chmielewski
April 1996, Drug design and discovery,
S Yao, and R Zutshi, and J Chmielewski
January 1993, Annual review of biochemistry,
Copied contents to your clipboard!